Intramuscular Administration
Articles & Whitepapers
-
Development of mRNA-Directed Delivery - LNP Delivery System
During the COVID-19 pandemic, the success of mRNA vaccines has greatly propelled the development of mRNA therapeutics. mRNA is a negatively charged nucleic acid that serves as a template for protein synthesis in ribosomes. Despite its utility, the instability of mRNA necessitates appropriate carriers for in vivo delivery. Currently, lipid nanoparticles (LNPs) are the most mature approach for ...
-
A Difficult Needle to Thread
Do you know what it’s like to wake up in a different stranger’s house every morning? To open your eyes and immediately feel extremely uncomfortable, alarmed, unsafe, out of ...
News
-
FDA Emerging Technology Program
Broomfield Colorado 6/16/2022. Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug ...
Zeneo® Adrenaline: A New Innovative Formulation
Treatment of Prostatitis - What Forms of Medicines Released?
Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)
Enalare Therapeutics Receives an Additional Award Worth Up to $50 Million From BARDA, Expanding Its Partnership in Development of ENA-001
Equipment & Solutions
-
Showcase
Needle-Free, Prefilled, Single-Use Auto-Injector
The ZENEO® system is the fruit of twenty years of R&D by a multidisciplinary team. The system calls upon the miniaturization and combination of cutting-edge technologies from various sectors: pharmaceutical manufacturing of course, but also space technologies, the automotive industry, glassworks and even defense.